Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Interim Results

16 Mar 2020 07:00

RNS Number : 1872G
CAP-XX Limited
16 March 2020
 

 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

 

16 March 2020

 

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Interim Results for the half-year ended 31 December 2019

 

 

CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, is pleased to announce its interim results for the half-year ended 31 December 2019.

 

Key highlights

 

· Project to transfer the former Murata manufacturing assets has made excellent progress with key project deliverables and milestones remaining on track

· Total Sales Revenue of A$1.9 million (2018: A$1.6 million) up 21%

· EBITDA loss of A$0.8 million continues to improve (2018: loss of A$1 million)*

· Gross margin of 55.4% (2018: 54.1%) has increased due to sales revenue mix

· Royalty and license fees of A$0.6 million (2018: A$0.4 million) are up, due to increased activity levels from both Murata and AVX

· Licence Agreement with Cornell-Dubilier announced. A number of other parties in negotiations

· Operating expenses of A$2.9 million, excluding share-based payments expense, held broadly flat on a year-on-year basis

· Cash reserves at the end of December 2019 were A$1.8 million (2018: A$4.6 million) which includes the proceeds of the R&D Tax Rebate of A$1.6 million, but does not include the capital raise related to the Murata transaction (net £3.42 million) which was received in January 2020

· Whilst the coronavirus outbreak has affected certain customer orders and their contract manufacturer suppliers, the impact on the Company to date from this has been minimal

* EBITDA excludes amortisation of employee share options.

 

Anthony Kongats, CEO of CAP-XX said:

"Late last year, we announced the acquisition of Murata's supercapacitor production assets. Since then we have completed the necessary capital raising and moved forward with the next stage of this project. The project remains on track and within budget and we are confident that the production lines will be recommissioned to start shipments to customers in the first quarter of the next financial year. We are also pleased to report that the rest of the business continues to perform well."

 

Electronic copies of CAP-XX's interim results for the half-year ended 31 December 2019 will shortly be available from the Company's website: www.cap-xx.com.

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

Chairman's statement

Much of the Company's focus for the six months ended 31 December 2019 has been involved with the preparation, completion and delivery of the previously announced acquisition of the supercapacitor production assets of Murata. The Board is pleased to report that excellent progress has been made and that this project remains on track, with project milestones and key deliverables being achieved as per the detailed project plan. A lease has been secured on a new 3,300 sq. metre facility in Western Sydney, which will house the former Murata production lines; the first shipment of equipment left Murata's factory on schedule; and three new engineers have been recruited together with a Head of Sales for North America. The process of transition of production to the new lines remains on schedule and within budget and the Board still expects that the recommissioned production lines will be in production and shipping to customers in the first quarter of the financial year to 30 June 2021.

 

Whilst significant resource has been dedicated to the successful relocation of the Murata equipment, focus has not been shifted from CAP-XX's existing operations and significant progress has been made on the realisation of the Company's medium-term goals. Gross margin has again improved from the previous year in both quantum and percentage terms, due to the year-on-year increase in sales revenue, changes to the sales product mix and operational cost savings. Year-on-year sales revenue performance has been buoyed by the increase in demand for CAP-XX's cylindrical can products, coupled with increased royalty receipts from both AVX and Murata.

 

As was highlighted in previous statements and trading updates, the sales pipeline for both prismatic and cylindrical can supercapacitors remain at historically high levels and this has resulted in the level of unfulfilled orders as at December 2019 being up significantly from the previous year. It is also one the reasons for the 21% increase in year-on-year sales performance. Certain of the Company's customers and suppliers, especially in the Asian region, have advised that the outbreak of the coronavirus is beginning to have a negative trading impact on their businesses. Some customers who have placed orders are asking for delivery dates to be extended and their contract manufacturers have decreased production activities due to the unavailability of staff and materials. To date, the impact on the Company from the outbreak of the coronavirus has been minimal. It is still too early to forecast the shorter to medium-term financial impact on the Company, although this will become evident in the next few months of trading.

 

Total revenue for the six months to 31 December 2019 was A$1.9 million (2018: A$1.6 million). Both product sales and revenue generated from royalties and licenses were significantly up from the previous year. For the six-month operating period ended 31 December 2019, the EBITDA loss of A$0.8 million (2018: EBITDA loss of A$1.0 million), which excludes the amortisation of share based payment expenses, improved by A$0.2 million or 21% from the previous year and is broadly in line with management's expectations. Cash reserves as at 31 December 2019 were A$1.8 million (2018: A$4.6 million), which included the proceeds from the R&D Tax Rebate which was received in December 2019, but does not include the proceeds of the capital raising associated with the Murata transaction (net £3.42 million).  Cash reserves as at the end of February 2020 stood at A$6.4 million.

 

The Company continues to pursue several competitor supercapacitor organisations in potential patent infringement cases. The Company announced in July 2019 that it had completed a licence agreement with Cornell-Dubilier of the USA. The Company remains in negotiations with a number of other parties and the Board remains confident that the Company's efforts in this process will bear fruit in the short to medium term. Given the overall importance of the Murata transaction, the Board and Company have agreed that a risk benefit analysis will be undertaken on the remining patent infringement targets to ensure that the Company's resources are being prioritised towards realisable gains.

 

Work continues on the Company's 3 Volt prismatic supercapacitor product to adapt it to the Murata production lines and on new chemistries to further improve product life and performance. The Board remains confident that its 3 Volt prismatic supercapacitors will be a significant source of revenue going forward.

 

The commissioning of the Murata plant and equipment will be the Company's main focus over the next six months and the Board is confident of reporting on a successful transition when the report and accounts for the full year to 30 June 2020 are released later in the current year.

 

 

Patrick Elliott

Chairman

 

 

 

 

 

CAP-XX Limited

Consolidated statement of profit or loss

For the half-year ended 31 December 2019

 

 

Consolidated

 

 

 

Half-year 2019

Half-year 2018

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Revenue from sale of goods and services

 

1,932,591

1,603,484

Cost of sale of goods and services

 

(862,558)

(735,147)

Gross margin (loss) on sale of goods and services

 

1,070,033

868,337

 

 

 

 

Other revenue

 

9,964

9,519

Other income

 

941,678

884,211

 

 

 

 

General and administrative expenses

 

(1,205,098)

(1,067,995)

Process and engineering expenses

 

(478,521)

(552,131)

Selling and marketing expenses

 

(404,326)

(339,220)

Research and Development expenses

 

(746,771)

(809,812)

Share based payments

 

(173,774)

(567,813)

Other expenses

 

(42,127)

(41,468)

(Loss) before income tax

 

(1,028,942)

(1,616,372)

 

 

 

 

Income tax benefit/(expense)

 

-

-

Net loss after income tax for the half year

 

(1,028,942)

(1,616,372)

 

 

 

 

(Loss) attributable to members of CAP-XX Limited

 

(1,028,942)

(1,616,372)

 

 

 

 

Loss per share attributable to the ordinary equity holders of the company

 

Cents

Cents

Basic loss per share

 

(0.32)

(0.52)

Diluted loss per share

 

(0.32)

(0.52)

 

 

 

 

     

 

 

 

CAP-XX Limited

Consolidated statement of comprehensive income

For the half year ended 31 December 2019

 

 

 

Consolidated

 

 

 

 

 

 

 

 

2019

2018

 

Currency: Australian Dollars

 

$

$

 

Loss for the half year

 

(1,028,942)

(1,616,372)

 

Other comprehensive income

 

 

 

 

Items that may be reclassified subsequently to profit or loss

 

 

 

 

 

 

Exchange differences on translation of foreign operations

 

(13,919)

(38,496)

 

Other comprehensive loss for the half year, net of tax

 

(13,919)

(38,496)

 

Total comprehensive loss for the half year attributable to owners of CAP-XX Limited

 

(1,042,861)

(1,654,868)

 

 

 

 

 

CAP-XX Limited

Consolidated statement of financial position

As at 31 December 2019

 

 

 

Consolidated

 

 

 

31 December 2019

31 December 2018

 

 

 

 

 

 

 

Currency: Australian Dollars

 

 

$

$

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

 

1,751,424

4,623,238

 

Receivables

 

 

466,152

327,296

 

Inventories

 

 

1,503,159

1,998,065

 

Other

 

 

1,629,358

921,106

 

Total current assets

 

 

5,350,093

7,869,705

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment

 

 

1,110,317

590,138

 

Other

 

 

236,507

236,507

 

Total non-current assets

 

 

1,346,824

826,645

 

 

 

 

 

 

 

TOTAL ASSETS

 

 

6,696,917

8,696,350

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

Current liabilities

 

 

 

 

 

Payables

 

 

546,399

835,112

 

Provisions

 

 

833,431

734,425

 

Total current liabilities

 

 

1,379,830

1,569,537

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Provisions

 

 

41,738

125,018

 

Total non-current liabilities

 

 

41,738

125,018

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

1,421,568

1,694,555

 

 

 

 

 

 

 

NET ASSETS

 

 

5,275,349

7,001,795

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

Contributed equity

 

 

101,915,665

101,867,507

 

Reserves

 

 

6,192,848

5,741,487

 

Accumulated losses

 

 

(102,833,164)

(100,607,199)

 

TOTAL EQUITY

 

 

5,275,349

7,001,795

 

 

 

 

 

 

CAP-XX Limited

Consolidated statements of changes in equity

For the half-year ended 31 December 2019

 

Consolidated

 

 

 

 

Contributed

Equity

$

Reserve

$

Accumulated losses

$

Total

$

 

 

 

 

 

 

Balance at 1 July 2018

 

98,565,062

5,212,170

(98,990,827)

4,786,405

Loss for the period as reported in the 2019 financial statements

 

(2,813,395)

(2,813,395)

 

Other comprehensive loss

 

- 

(38,660)

-

 

(38,660)

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

3,350,603

 

 

3,350,603

Employee share options ‑ value of employee services

 

 

-

859,483

-

859,483

 

 

 

 

 

 

Balance at 30 June 2019

 

101,915,665

6,032,993

(101,804,222)

 6,144,436

 

Profit for the period as reported in the 2019 interim financial statements

 

- 

-

(1,028,942)

(1,028,942)

Other comprehensive income

 

- 

(13,919)

-

 

(13,919)

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

 -

 -

 -

-

Employee share options ‑ value of employee services

 

-

173,774

-

173,774

 

 

 

 

 

 

Balance at 31 December 2019

 

101,915,665

6,192,848

 (102,833,164)

5,275,349

 

 

 

 

 

 

 

 

 

 

 

 

CAP-XX Limited

Consolidated Statement of Cash Flows

For the half-year ended 31 December 2019

 

 

Consolidated

 

 

Half-year

2019

Half-year 2018

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Cash flows from operating activities

 

 

 

Receipts from customers (inclusive of goods and services tax)

 

1,913,899

2,259,627

Payments to suppliers and employees (inclusive of goods and services tax)

 

(3,642,199)

(4,303,597)

 

 

(1,728,300)

(2,043,970)

Tax credit received

 

1,592,042

1,596,547

Interest received

 

9,964

9,519

Net cash (outflow) from operating activities

 

(126,294)

(437,904)

 

 

 

 

Cash flows from investing activities

 

 

 

Payments for property, plant and equipment

 

(537,519)

(114,153)

Net cash (outflow) from investing activities

 

(537,519)

(114,153)

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issue of shares

 

-

3,302,445

Net cash inflow from financing activities

 

-

3,302,445

 

 

 

 

Net (decrease) in cash and cash equivalents

 

(663,813)

2,750,388

Cash and cash equivalents at the beginning of the half-year

 

2,429,156

1,911,346

Effects of exchange rate changes on cash and cash equivalents

 

(13,919)

(38,496)

Cash and cash equivalents at the end of the half-year

 

 

1,751,424

4,623,238

 

 

 

 

 

 

 

 

This general purpose interim financial report, for the half-year reporting period ended 31 December 2019, has been prepared in accordance with Australian equivalents to International Financial Reporting Standards (AIFRSs), other authoritative pronouncements of the Australian Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001. This general purpose interim financial report, for the half-year reporting period ended 31 December 2019, is unaudited.

 

 

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR JAMFTMTIBBJM
Date   Source Headline
2nd Feb 20267:00 amRNSInterim Results
23rd Jan 20267:00 amRNSNotice of Interim Results & Investor Presentation
19th Dec 202510:13 amRNSReceipt of R&D tax credit
19th Dec 202510:13 amRNSReceipt of R&D tax credit
10th Dec 20252:16 pmRNSHolding(s) in Company
28th Nov 20255:00 pmRNSTotal Voting Rights
28th Nov 202510:13 amRNSResult of AGM
14th Nov 20257:00 amRNSIssue of Shares and Director/PDMR Shareholding
10th Nov 20257:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSFinal results and notice of AGM
30th Oct 20251:02 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSImplementation of Warehouse Management System
10th Sep 202511:48 amRNSHolding(s) in Company
7th Aug 20257:00 amRNSHolding(s) in Company
5th Aug 20257:00 amRNS-RDesign Win with Global Semiconductor Manufacturer
31st Jul 20255:00 pmRNSTotal Voting Rights
25th Jul 20257:00 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSUpdate re. collaboration with SCHURTER
2nd Jul 20257:00 amRNSHolding(s) in Company
1st Jul 20257:29 amRNSIssue of Shares and Director/PDMR Shareholdings
30th Jun 20257:00 amRNSGlobal Distribution Agreement with RS Group plc
9th Jun 20257:00 amRNSBusiness Update and Appointment of Interim CFO
30th May 202510:32 amRNS-RUpdated website
13th May 202511:31 amRNS-RDesign Win with Multinational Conglomerate
30th Apr 20251:57 pmRNSChange of Auditor
26th Mar 20257:00 amRNSGrant of share options
19th Mar 20257:00 amRNSChange of Board Structure and Grant of Options
18th Mar 20259:35 amRNSGlobal Distribution Agreement with Premier Farnell
12th Mar 20252:43 pmRNSTechnology Cooperation Agreement with SCHURTER
7th Mar 20257:00 amRNSMaster Distribution Agreement with Waldom
17th Feb 20257:00 amRNSHalf-year Results
11th Feb 20257:00 amRNSNotice of Interim Results & Investor Presentation
31st Jan 20255:00 pmRNSTotal Voting Rights
21st Jan 20254:27 pmRNSIssue of Shares and Director/PDMR Shareholding
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
17th Jan 20257:00 amRNS-RDistribution agreement with JM Elektronik
15th Jan 20257:00 amRNSFirst shipment to SCHURTER AG
13th Jan 202511:29 amRNSResult of AGM
7th Jan 20257:00 amRNSManagement and board changes
31st Dec 20241:00 pmRNSTotal Voting Rights
9th Dec 202410:19 amRNSNotice of AGM
5th Dec 20248:18 amRNSResult of General Meeting
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20249:57 amRNSDirectors' Subscription
29th Nov 20247:00 amRNSAudited results for the year ended 30 June 2024
5th Nov 20247:00 amRNSResult of Retail Offer, Notice of GM and TVR
1st Nov 20247:00 amRNSResult of Placing
31st Oct 20244:40 pmRNSRetailBook Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.